Moneycontrol PRO
Loans
Loans
HomeAuthorR sree ram Opinion

R. Sree Ram

News Editor

Moneycontrol

How Bharat Electronics is withstanding the COVID-19 disruption better

BUSINESS

How Bharat Electronics is withstanding the COVID-19 disruption better

Bharat Electronics sees a strong recovery in September quarter, expects order inflows in the current fiscal to exceed previous year's levels

Gujarat Pipavav charts growth path, regulator consent key

BUSINESS

Gujarat Pipavav charts growth path, regulator consent key

Dedicated freight corridor connectivity can help Gujarat Pipavav gain market share. The expansion plan is subject to approval from the regulator

Renewable energy capacity additions turn the corner, but challenges persist

TRENDS

Renewable energy capacity additions turn the corner, but challenges persist

Renewable energy sector is recovering from COVID-19 disruption. Capacity additions are set to gather pace as work on delayed projects resumes

Wipro’s no margin pain reorganisation plan awaits execution test

BUSINESS

Wipro’s no margin pain reorganisation plan awaits execution test

Wipro new CEO Theirry Delaporte elaborated on the revival plan at an analyst meet. The focus is on growth acceleration and simplification of the organisation structure

Why NBCC's giant order book inspires limited confidence

BUSINESS

Why NBCC's giant order book inspires limited confidence

NBCC’s order book more than tripled in five years to FY20. But its revenues lagged on slow execution and weak asset monetisation

Q2 results show Apollo Hospitals better placed on earnings, but Fortis is closing in on recovery

BUSINESS

Q2 results show Apollo Hospitals better placed on earnings, but Fortis is closing in on recovery

Both Apollo Hospitals and Fortis Healthcare see notable recovery in hospitals business in the September quarter. While Fortis expects the business to normalise by June next year, the recovery in retail healthcare centres can aid Apollo’s earnings

The silver lining in Big Pharma’s September quarter results

BUSINESS

The silver lining in Big Pharma’s September quarter results

US revenues of large pharma companies improved from the June quarter. The companies benefited from new product launches and moderation in pricing pressure

With debt receding, all Tata Power needs now is a little help at Mundra

BUSINESS

With debt receding, all Tata Power needs now is a little help at Mundra

Tata Power's September quarter results show notable reduction in debt. The company saw funds infusion from promoters and realised proceeds from stake sales

What the TCS-Deutsche Bank deal says about demand for IT services

BUSINESS

What the TCS-Deutsche Bank deal says about demand for IT services

The acquisition of Postbank Systems AG from Deutsche Bank by TCS illustrates how Indian IT is transcending technology budgets to capture business

Indian Railways’ new fee structure could derail Concor profitability

BUSINESS

Indian Railways’ new fee structure could derail Concor profitability

Concor's September quarter results statement shows a significant rise in demand for land licence fee by the Ministry of Railways

Biden win brings reprieve for Indian IT, but major visa relaxations not guaranteed

BUSINESS

Biden win brings reprieve for Indian IT, but major visa relaxations not guaranteed

A Biden administration may take a more balanced approach to US immigration and visa policy, but a split Congress and a weak US economy are risks

Confidence returns at Adani Ports, reduction in promoter pledges of shares key

BUSINESS

Confidence returns at Adani Ports, reduction in promoter pledges of shares key

Adani Ports resumed its annual guidance after a recovery in business volumes. While the company expects to clock modest growth in the current fiscal, stock pledges by promoters rose significantly

COVID-19 product pipeline and debt reduction add zing to Cadila Healthcare

BUSINESS

COVID-19 product pipeline and debt reduction add zing to Cadila Healthcare

Cadila Healthcare is working on a potential COVID-19 vaccine and drugs. With key markets, India and the US returning to growth, the success of COVID-19 initiatives can add to the company's revenue momentum

Auditor conundrum adds to debt concerns at UPL

BUSINESS

Auditor conundrum adds to debt concerns at UPL

The resignation of an auditor at a key subsidiary without a convincing explanation is stoking concerns at UPL. While the company maintained FY21 revenue growth guidance, performance in the September quarter is mixed

Hospital occupancy picking up at Fortis, but business normalisation some time away

BUSINESS

Hospital occupancy picking up at Fortis, but business normalisation some time away

Occupancy at hospitals improving after a sharp fall in April-June. While diagnostic business is seeing faster rebound, postponement of hospital visits by patients can weigh on recovery

Dr Reddy’s revs up product launches after costs recalibration, execution key

BUSINESS

Dr Reddy’s revs up product launches after costs recalibration, execution key

New product launch momentum is gathering pace at Dr Reddy’s Laboratories with the company targeting to introduce 30 drugs in the US this fiscal. While the company is also working on COVID-19 medicines, success is contingent on positive research outcomes

Business recovery adds heft to Tata Motors’ deleveraging plan

BUSINESS

Business recovery adds heft to Tata Motors’ deleveraging plan

Tata Motors’ September-quarter results indicate a material improvement in passenger vehicle business. A sustained improvement in profitability and sales can help the company achieve its deleveraging objective

Natrol sale marks a subtle shift in Aurobindo Pharma’s business strategy

BUSINESS

Natrol sale marks a subtle shift in Aurobindo Pharma’s business strategy

The Natrol sale will help Aurobindo Pharma focus on the core generic drug and injectable businesses

Why Aditya Birla Fashion-Flipkart partnership will yield results sooner than later

BUSINESS

Why Aditya Birla Fashion-Flipkart partnership will yield results sooner than later

Aditya Birla Fashion’s digital preparedness should help Flipkart derive synergies faster. The funds infusion will strengthen Aditya Birla Fashion’s financial position helping it invest in growth areas

 Resilient exports place Balkrishna Industries firmly on recovery path

BUSINESS

 Resilient exports place Balkrishna Industries firmly on recovery path

Exports of specialised tyres from India continue to see strong growth. This bodes well for Balkrishna Industries, a major exporter of agriculture and industrial tyres

Coal India’s volume recovery needs sustained support from thermal power

BUSINESS

Coal India’s volume recovery needs sustained support from thermal power

Coal India continues to see healthy growth in coal offtake, helped by improvement in thermal power generation

How ACC’s cost saving programme is yielding disproportionate earnings benefits

BUSINESS

How ACC’s cost saving programme is yielding disproportionate earnings benefits

ACC reported a healthy expansion in operating earnings despite subdued sales volumes. The company is benefiting from steady realisations and cost efficiency measures

Volume recovery to aid govt’s divestment efforts for Concor, but niggling worries remain

BUSINESS

Volume recovery to aid govt’s divestment efforts for Concor, but niggling worries remain

The improvement in container traffic at Indian Railways and major ports augurs well for Concor. But earnings benefits are uncertain as competitive intensity remains high

Seasonal softness test awaits big IT after broad-based recovery

BUSINESS

Seasonal softness test awaits big IT after broad-based recovery

Financial services and retail business verticals drive recovery at big four IT companies. While companies also saw good deal wins, managements warned that the December quarter may see some seasonal softness

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347